4.8 Article

TRIM25 inhibits influenza A virus infection, destabilizes viral mRNA, but is redundant for activating the RIG-I pathway

Journal

NUCLEIC ACIDS RESEARCH
Volume 50, Issue 12, Pages 7097-7114

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkac512

Keywords

-

Funding

  1. Polish Ministry of Science and Higher Education [2019/02/H/NZ1/00002]
  2. Polish National Agency for Academic Exchange within Polish Returns Programme [2021/01/1/NZ1/00001]
  3. Polish National Science Centre [2021/01/1/NZ1/00001]
  4. Wellcome Trust [105246/Z/14/Z]
  5. Wellcome Trust Seed Award [210144/Z/18/Z]
  6. BBSRC [BB/T002751/1, BB/S00114X/1]
  7. BBSRC Institute Strategic Programme [BB/J004324/1, BB/P013740/1]
  8. Wellcome Trust/Royal Society [21222 Z 18 Z]
  9. Wellcome Trust Centre Core Grants [077707, 092076]
  10. Wellcome Trust Instrument Grant [091020]
  11. UKRI Open Access Fund
  12. Dioscuri Centre
  13. German Federal Ministry of Education and Research [2019/02/H/NZ1/00002]
  14. Wellcome Trust [210144/Z/18/Z, 105246/Z/14/Z] Funding Source: Wellcome Trust

Ask authors/readers for more resources

TRIM25 is an E3 ubiquitin ligase that plays a key role in the innate immune response to RNA viruses. It has been shown to bind to RNA, but the exact role of its RNA-binding activity in the immune response is unclear.
The E3 ubiquitin ligase TRIM25 is a key factor in the innate immune response to RNA viruses. TRIM25 has been shown to play a role in the retinoic-acid-inducible gene-1 (RIG-I) pathway, which triggers expression of type 1 interferons upon viral infection. We and others have shown that TRIM25 is an RNA-binding protein; however, the role of TRIM25 RNA-binding in the innate immune response to RNA viruses is unclear. Here, we demonstrate that influenza A virus (IAV A/PR/8/34_NS1(R38A/K41A)) infection is inhibited by TRIM25. Surprisingly, previously identified RNA-binding deficient mutant TRIM25 Delta RBD and E3 ubiquitin ligase mutant TRIM25 Delta RING, which lack E3 ubiquitin ligase activity, still inhibited IAV replication. Furthermore, we show that in human-derived cultured cells, activation of the RIG-I/interferon type 1 pathway mediated by either an IAV-derived 5 '-triphosphate RNA or by IAV itself does not require TRIM25 activity. Additionally, we present new evidence that instead of TRIM25 directly inhibiting IAV transcription it binds and destabilizes IAV mRNAs. Finally, we show that direct tethering of TRIM25 to RNA is sufficient to downregulate the targeted RNA. In summary, our results uncover a potential mechanism that TRIM25 uses to inhibit IAV infection and regulate RNA metabolism.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available